For more detailed insights, readers are encouraged to refer to the full transcript. Peter Lawson, Biotech Analyst ... That’s an SPLA for KIMTRAC. And obviously high on med needs setting first Phase ...

Peter Lawson, SMIDCAP Biotech Analyst ... Sites that are really doing very well. There’s very high interest in this trial both by investigators and by patients. There’s really a scramble to get into ...

For more detailed insights, readers are encouraged to refer to the full transcript. Peter Lawson, Biotech Analyst ... And obviously high on med needs setting first Phase three trial that is ...

Peter Lawson, Biotech Analyst, Barclays ... So now you have a true off the shelf product, very cost effective in an outpatient setting. And with the recent high C meeting we have with the FDA, we got ...

Peter Lawson, Biotech Analyst ... very cost effective in an outpatient setting. And with the recent high C meeting we have with the FDA, we got the green light to multi dose and dose upon relapse.

Peter Lawson, SMIDCAP Biotech Analyst ... Sites that are really doing very well. There’s very high interest in this trial both by investigators and by patients. There’s really a scramble ...

The full transcript of the conference call provides further insights into Perspective Therapeutics’ strategic direction and innovations. Peter Lawson, Biotech Analyst ... Some receptors have a very, ...

TORONTO — A.J. Lawson of Brampton, Ont., came off Toronto’s bench for a career-high 32 points as the Raptors beat the Washington Wizards 119-104 on Monday. Lawson added 12 rebounds as four Toronto ...

TORONTO - A.J. Lawson of Brampton, Ont., came off Toronto's bench for a career-high 32 points as the Raptors beat the Washington Wizards 119-104 on Monday. Lawson added 12 rebounds as four Toronto ...